XML 57 R49.htm IDEA: XBRL DOCUMENT v2.4.0.8
Subsequent Event - Additional Information (Detail) (Subsequent Event)
In Millions, unless otherwise specified
0 Months Ended 0 Months Ended
Jul. 31, 2014
Insulin [Member]
EUR (€)
Aug. 11, 2014
License and Collaboration Agreement with Sanofi
USD ($)
Aug. 11, 2014
License and Collaboration Agreement with Sanofi
USD ($)
Aug. 11, 2014
License and Collaboration Agreement with Sanofi
Second Amendment Facility Agreement
USD ($)
Aug. 11, 2014
License and Collaboration Agreement with Sanofi
Sanofi-Aventis Deutschland GmbH
Jul. 18, 2014
Deerfield
Senior convertible notes due December 31, 2019
Fourth tranche
USD ($)
Subsequent Event [Line Items]            
Principal amount of notes purchased           $ 40.0
Purchase annual minimum quantities under Supply Agreement 120.1          
Upfront fee   150.0        
Potential milestone payment     775.0      
Profits and losses sharing percentage   35.00%     65.00%  
Maximum secured loan facility       $ 175.0